| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-07 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |